Journal
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
Volume 8, Issue 2, Pages 322-327Publisher
AMER SOC NEPHROLOGY
DOI: 10.2215/CJN.04260412
Keywords
-
Categories
Funding
- National Institutes of Health [5T32DK007470, 5R01DK080123]
Ask authors/readers for more resources
Treatment of uremia by hemodialysis has become widespread over the last 40 years and has improved substantially over that time. However, people treated with this modality continue to suffer from multiple disabilities. Retention of organic solutes, especially those poorly removed by hemodialysis, likely contributes to these disabilities. Certain classes of solutes are removed less well than urea by hemodialysis and by the normal kidney. These include protein-bound solutes, relatively large solutes, sequestered compounds, and substances removed at rates higher than urea by the normal kidney. Several strategies could be used to discover the solutes responsible for residual morbidities in standardly dialyzed people. Rather than continue to focus only on urea removal as an index for dialysis adequacy, finding additional approaches for removing toxic solutes with characteristics different from, urea (and the similar small solutes it represents) is a desirable and feasible goal. Clin J Am Soc Nephrol 8: 322-327,2013. doi: 10.2215/CJN.04260412
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available